BIOLASE, Inc. To Report Second Quarter 2021 Results On August 12, 2021
BIOLASE, a leader in dental lasers, will announce its second quarter 2021 financial results on August 12, 2021. The results will be released after the U.S. market close, followed by a conference call at 4:30 p.m. ET. U.S./Canada participants can join by calling (800) 367-2403, while international participants can call (334) 777-6978, using Conference ID 9019839. An audio archive of the conference will be available for 30 days on the BIOLASE website.
- None.
- None.
FOOTHILL RANCH, Calif., Aug. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2021 financial and operating results on Thursday, August 12, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 367-2403. For international participants outside the U.S./Canada, the dial-in number is (334) 777-6978. For all callers, refer to the Conference ID 9019839. To access the live webcast, go to BIOLASE Investor Events Page.
An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-inc-to-report-second-quarter-2021-results-on-august-12-2021-301349000.html
SOURCE BIOLASE, Inc.
FAQ
When will BIOLASE announce its second quarter 2021 results?
What time is the BIOLASE conference call on August 12, 2021?
How can I join the BIOLASE conference call?
What is the conference ID for the BIOLASE call?
Where can I access the audio archive of the BIOLASE conference call?
